Clalit Health Services

Essence SmartCare and Clalit Health Services Launch Pilot with Sharan Medical Care to Implement VitalOn Telehealth Platform to Reduce Hospitalization Rates in Israel

Retrieved on: 
Monday, March 14, 2022
Hypertension, Safety, Heart, Patient, Vital signs, General manager, Texas Homecare, Rehabilitation, Health, Nursing, HMO, Smartphone, Diabetes, Association, Internal medicine, Medical director, Claudio Vitalone, Medication, COVID-19, Professional, Disease, Program, CEO, Founder, Medicine, Hospital, Pharmaceutical industry, Hospital, Clalit Health Services

HERZLIYA, Israel, March 14, 2022 /PRNewswire/ -- Essence SmartCare, a leader in remote care and telehealth solutions and services, announced today the successful completion of a pilot program with Clalit Health Services, Israel's largest HMO, and homecare provider Sharan Medical Care, to implement its VitalOn remote patient monitoring platform.

Key Points: 
  • "We are honored to have been selected by Clalit Health Services for the first implementation of this solution in Israel."
  • VitalOn combines telecare, telehealth, and wellness capabilities into a single, comprehensive remote patient monitoring and chronic disease management platform.
  • The collaboration with Essence SmartCare and Sharan expands our ability to monitor patients and provides important tools for monitoring their vital signs."
  • Sharan provides comprehensive medical and health-care services, enabling hospital quality care to be provided in the comfort of the patient's own home.

Pulsenmore Secures Multimillion-Dollar Contract with Clalit Health Services for Home Ultrasound Device for Use in IVF Processes

Retrieved on: 
Monday, January 3, 2022
Online, COVID-19, Fetal monitoring, Privacy, Woman, Fertilisation, Solution, Pregnancy, Tel Aviv Stock Exchange, Research, Fertility preservation, Marketing, Patient, TASE, Efficiency, Breast self-examination, Technology, Egg, Medical device, Medical imaging, IVF, Clalit Health Services

RAMAT GAN, Israel, Jan. 3, 2022 /PRNewswire/ -- Home ultrasound developer Pulsenmore has secured a multimillion-dollar contract to supply its home ultrasound device for self-examination of follicles in IVF (in vitro fertilization) and fertility preservation processes to Clalit Health Services, Israel's largest healthcare organization.

Key Points: 
  • RAMAT GAN, Israel, Jan. 3, 2022 /PRNewswire/ -- Home ultrasound developer Pulsenmore has secured a multimillion-dollar contract to supply its home ultrasound device for self-examination of follicles in IVF (in vitro fertilization) and fertility preservation processes to Clalit Health Services, Israel's largest healthcare organization.
  • This is the second agreement Pulsenmore has secured with Clalit, following an earlier contract to provide the organization with its flagship home device for fetal ultrasound, Pulsenmore ES, including an initial order of $6 million.
  • The device was immediately rolled out to Clalit patients and to date, almost 15,000 Pulsenmore home ultrasound scans have been performed by pregnant women and reviewed by Clalit's healthcare professionals.
  • The new follicular tracking ultrasound device, Pulsenmore FC, will enable Clalit's fertility patients to perform ultrasound scans at home, which are then viewed and assessed remotely by her healthcare professional.

Immunicom Announces Promising Preliminary Data from its Immunopheresis® Study in Late-Stage Cancer and Metastatic Melanoma Patients Presented at 2021 SITC Congress

Retrieved on: 
Tuesday, December 7, 2021
Oncology, Medical Devices, Health, Clinical Trials, Pharmaceutical, Biotechnology, Health, Principal investigator, Technology, Cancer, Clalit Health Services, CEO, Nivolumab, CE marking, Blood, Publication, Rabin Medical Center, Food, Patient, Multimedia, ISO, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Jagiellonian University, Immunotherapy, Society for Immunotherapy of Cancer, Plasma, Melanoma, Certification, FDA, Society, Degenerative disease, Congress, TNBC, Toxicity, Immune system, Newsweek, Safety, Quality of life, TNF, Large-cell lung carcinoma, PD-L1, Sheba Medical Center, MD, Clinical trial, Survival, Doctor of Philosophy, Hospital, SITC, Pharmaceutical industry, Vaccine, Medical device, Immunicom, Sheba Medical Center at Tel Hashomer, IMMUNICOM, SHEBA MEDICAL CENTER AT TEL HASHOMER

By depleting TNF receptors from plasma, this therapy is designed to free the cytokine TNF-alpha, thereby unleashing its potent anti-cancer effects.

Key Points: 
  • By depleting TNF receptors from plasma, this therapy is designed to free the cytokine TNF-alpha, thereby unleashing its potent anti-cancer effects.
  • Preliminary data were presented from Part A (Immunopheresis therapy alone) from six patientsthree with melanoma, and three with triple negative breast cancer (TNBC)who have failed multiple prior lines of standard chemo and immunotherapies.
  • Of these six heavily pretreated patients, three completed the 12-week study regimen, and three were withdrawn due to clinical progression.
  • Immunopheresis therapy was well-tolerated in these late-stage patients, and no treatment-related serious adverse events were reported.

Zeev Vurembrand to Join ScoutCam's Board of Directors

Retrieved on: 
Wednesday, May 19, 2021
Health maintenance organizations, Clalit Health Services, Kupat Holim Meuhedet, Benad Goldwasser, Organizations, Technion – Israel Institute of Technology, Health, Economy

b'OMER, Israel, May 19, 2021 (GLOBE NEWSWIRE) -- ScoutCam (OTCQB:SCTC), a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, today announced that Mr. Zeev Vurembrand has been appointed to its board of directors.

Key Points: 
  • b'OMER, Israel, May 19, 2021 (GLOBE NEWSWIRE) -- ScoutCam (OTCQB:SCTC), a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, today announced that Mr. Zeev Vurembrand has been appointed to its board of directors.
  • Mr. Vurembrand was previously the Chief Executive Officer of Clalit Health Services Group and Kupat Holim Meuhedet, Israel\xe2\x80\x99s largest and third largest health care organizations, respectively, Alon Holding Blue Square, and Phoenix Investments.
  • Vurembrand is a graduate of Technion, Israeli Institute of Technology, where he earned a degree in industrial engineering and management.\n\xe2\x80\x9cWe are very pleased to add the support of Mr. Vurembrand to our Board of Directors", said Prof. Benad Goldwasser, the Executive Chairman of the Board.
  • Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.\n'

CommBox, The Leading AI Customer Communication Platform Land A 4.4M$ Deal Size To Empower The Most Efficient Healthcare Service - Clalit, Regarding COVID-19 Vaccinations

Retrieved on: 
Thursday, January 21, 2021
Health maintenance organizations, Clalit Health Services, Histadrut, Health care, Health

The organization provides its services to over 50% of the residents of the State of Israel!

Key Points: 
  • The organization provides its services to over 50% of the residents of the State of Israel!
  • The total deal size is $4.4 USD for a period of 5 years and will include 4,000 seats.
  • This will undoubtedly save significantly on operational costs, but above all it indicates the tremendous importance customer service and customer experience now have also in the healthcare space.
  • Clalit's project joins a group of health services in Israel that already use the multi-channel platform of CommBox, including: Mada, the Ministry of Health, Maccabi, Meuhedet, and Leumit HMO.

The Helmsley Charitable Trust Awards Clalit Health Services $3.4M to Evaluate Closed-loop AI Technology at Schneider Children’s Medical Center for People Requiring Insulin Injection Therapy

Retrieved on: 
Monday, November 23, 2020
Software, Practice Management, Managed care, Health, Diabetes, Hospitals, Technology, Other Technology, Organ systems, Health, Clinical medicine, Diabetes, Clalit Health Services, Insulin, Type 1 diabetes

Clalit Health Services announces a $3,419,910 grant received from The Leona M. and Harry B. Helmsley Charitable Trust to clinically evaluate the efficacy of real-time AI decision support technology.

Key Points: 
  • Clalit Health Services announces a $3,419,910 grant received from The Leona M. and Harry B. Helmsley Charitable Trust to clinically evaluate the efficacy of real-time AI decision support technology.
  • Clalit Health Services will conduct the research at its Schneider Childrens Medical Centers Jesse Z and Sara Lea Shafer Institute of Endocrinology and Diabetes, a national referral center for childhood diabetes in Israel.
  • Diabetes is a demanding chronic condition that can take a heavy toll on affected individuals as well as the healthcare system.
  • Most people with diabetes requiring insulin are using injections therapy, with few alternative treatment options available.

Zebra Medical Vision And Clalit to Deploy Imaging AI in a Large Scale Enterprise

Retrieved on: 
Monday, November 16, 2020
Software, Radiology, Managed care, Health, Medical devices, Data management, Hospitals, Technology, Clalit Health Services, Histadrut, Medical imaging, Medicine, Health care, Health

Zebra Medical Vision, ( https://www.zebra-med.com/ ), the deep-learning medical imaging analytics company partners with Clalit Health Services, the largest mandated health service organization in Israel, to become the first in the world to bring cloud-based imaging AI to a large scale HMO.

Key Points: 
  • Zebra Medical Vision, ( https://www.zebra-med.com/ ), the deep-learning medical imaging analytics company partners with Clalit Health Services, the largest mandated health service organization in Israel, to become the first in the world to bring cloud-based imaging AI to a large scale HMO.
  • Over the past six years, Clalit and Zebra-Med have established commercial and data-sharing collaboration, ultimately resulting in Clalit spearheading the global adoption of artificial intelligence in medical imaging, as a means for driving innovation.
  • Zebra Medical Visions imaging analytics platform allows healthcare institutions to identify patients at risk of disease and offer improved, preventative treatment pathways, to improve patient care.
  • Zebra Medical Vision has raised $52 million in funding to date, and was named a Fast Company Top-5 AI and Machine Learning company.

At-Home Ultrasounds for Pregnant Women Now A Reality: PulseNmore Launches World's First Self-Administered Handheld Tele-Ultrasound Device

Retrieved on: 
Monday, August 10, 2020
Acoustics, Medical equipment, Physical therapy, Medical imaging, Medicine, Medical ultrasonography, Health care, Medical ultrasound, Health, Ultrasound, Clalit Health Services

"At home tele-ultrasound scanning is a major leap forward in digital medicine and prenatal health," said Dr. Elazar Sonnenschein, Founder and CEO of PulseNmore.

Key Points: 
  • "At home tele-ultrasound scanning is a major leap forward in digital medicine and prenatal health," said Dr. Elazar Sonnenschein, Founder and CEO of PulseNmore.
  • The device provides quick and convenient peace of mind and can potentially reduce unnecessary visits to the emergency room.
  • PulseNmore plans to build on the success of the Clalit implementation by entering key European markets in the near future.
  • PulseNmore has developed a handheld device that allows pregnant women to perform ultrasound scans on their unborn babies from the comfort of their home.

Mor Research Applications, a Division of Clalit Health Services, Invests in Aspire Ventures and Smart Health Innovation Lab

Retrieved on: 
Tuesday, May 14, 2019
Technology, Data management, Internet, Practice Management, Health, Hospitals, Professional services, Finance, Insurance, Managed care, Articles, Health maintenance organizations, Clalit Health Services, Histadrut, Technology transfer, Innovation, Technology, Data management, Internet, Practice Management, Health, Hospitals, Professional services, Finance, Insurance, Managed care, Articles, Health maintenance organizations, Clalit Health Services, Histadrut, Technology transfer, Innovation

Mor Research Applications, a subsidiary of Clalit Health Services, has agreed to join in the Aspire Ventures Precision Medicine Fund and Smart Health Innovation Lab (iLab).

Key Points: 
  • Mor Research Applications, a subsidiary of Clalit Health Services, has agreed to join in the Aspire Ventures Precision Medicine Fund and Smart Health Innovation Lab (iLab).
  • In return, worthy Israeli start-ups will benefit from unique commitments of U.S. health systems to provide contracts and reimbursement, said Essam Abadir, Managing Partner at Aspire.
  • Mor Research Applications is the Technology Transfer Office of Clalit Health Services.
  • As the tech transfer office of Clalit, Mor provides direct access to Israeli health tech innovation we can now expose to the U.S. markets.

BioSeedXL to Offer Services for BioTech and Cannabis Startups in Its Acceleration Program

Retrieved on: 
Thursday, March 28, 2019
Economy, Finance, Tel Aviv Stock Exchange, Financial markets, NASDAQ, Startup company, Clalit Health Services, Bnei Brak

BNEI BRAK, Israel, March 28, 2019 /PRNewswire/ -- After four companies successfully graduated from its acceleration program, BioSeedXL has decided to officially open its doors and offer its services to a select and hand-picked number of Biotech and Cannabis startup companies.

Key Points: 
  • BNEI BRAK, Israel, March 28, 2019 /PRNewswire/ -- After four companies successfully graduated from its acceleration program, BioSeedXL has decided to officially open its doors and offer its services to a select and hand-picked number of Biotech and Cannabis startup companies.
  • In addition, BioseedXL has deep experience in IPO's on the TASE and NASDAQ exchanges.
  • BioSeedXL is planning to support the business needs of startups and supply a variety of services as needed.
  • BioSeedXL has established an active partnership with one of its shareholders - MOR Research Applications, the tech transfer company of CLALIT HEALTH SERVICES.